All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @ahmadyasinmd on TikTok · 104s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @ahmadyasinmd's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00This peptide can give you lean muscle mass and make you lose fat quickly. This is Dr.
  2. 0:04Yasen. I talk peptides by regulators on storms. I help you lose fat, gain lean muscle and be
  3. 0:11great in bed again. This is CJC-1295. This peptide is available in two forms. One with
  4. 0:18DAC drug affinity complex for extended action and the other one without DAC for more pelsatile
  5. 0:24release of growth hormone. It amplifies the release of growth hormone naturally in your body,
  6. 0:29which eventually will lead to improved muscle mass, fat loss, recovery, sleep quality and overall
  7. 0:36performance. It's usually combined with epimoralin for a better profound effect. This combination is
  8. 0:42also used for anti-aging, performance enhancement and therapeutic protocol. It may also improve
  9. 0:48your bone health and is for neuroprotection. The common side effects, flushing, very common and
  10. 0:54people usually stop the medication because of that side effect. Sometimes irritation at the
  11. 1:01site of injection, joint pain and swelling. People with a study of cancer or active cancer,
  12. 1:06you have to be cautious when you use those kinds of peptides because anything with growth hormone
  13. 1:11may aggravate your cancer. Those thing is 100 microgram twice weekly, cycle for eight weeks on and then
  14. 1:18eight weeks off, usually taken in the morning. For combination with epimoralin, 200 to 400
  15. 1:25microgram daily for five days and then two days off, cycle for 90 days. This video is only for
  16. 1:32educational purposes. Do not buy or use any peptides without talking to your doctor. If you want to
  17. 1:37know more about the peptides world, please follow me and like the video and I'll see you in the next
  18. 1:41one. Thank you so much for watching.

@ahmadyasinmd's CJC-1295 claims need some fine print

Ahmad Yasin MD

TikTok creator

96.6K viewsWatch on TikTok

Quick answer

CJC-1295 is a synthetic GHRH analog studied for its ability to increase GH and IGF-1 levels in healthy adults, with the DAC formulation providing extended action through albumin binding. Clinical evidence for body composition benefits in non-GH-deficient individuals remains limited, and the compound currently falls outside FDA-approved compounding pathways in the US as of 2024. Use in patients with a history of cancer or active malignancy carries meaningful risk due to GH-mediated cell proliferation effects.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @ahmadyasinmd's CJC-1295 claims need some fine print, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@ahmadyasinmd's CJC-1295 claims need some fine print is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this cjc-1295 video claims cluster

Best for searchers checking whether growth-hormone peptide claims fit evidence, access, and safety realities.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@ahmadyasinmd's CJC-1295 claims need some fine print" from Ahmad Yasin MD. We read the clip as a Peptide social video fact-checks claim about CJC-1295, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: CJC-1295 is a synthetic GHRH analog studied for its ability to increase GH and IGF-1 levels in healthy adults, with the DAC formulation providing extended action through albumin binding.

The reason this review is not generic is the source wording and the canonical claim label "peptides cjc 1295 explained boost muscle burn fat sleep better a." In this clip, the useful excerpt is: "This peptide can give you lean muscle mass and make you lose fat quickly." That wording changes the review because it points to CJC-1295 evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Ipamorelin, the first selective growth hormone secretagogue (1998), The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation (2001), and Influence of chronic treatment with the growth hormone secretagogue Ipamorelin (2002), plus the creator's own wording. CJC-1295 decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The DAC vs.
People who land here are usually trying to understand whether the CJC-1295 claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' CJC-1295 guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

CJC-1295 is a synthetic GHRH analog studied for its ability to increase GH and IGF-1 levels in healthy adults, with the DAC formulation providing extended action through albumin binding.

FormBlends verdict

CJC-1295 evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • CJC-1295 is a synthetic GHRH analog studied for its ability to increase GH and IGF-1 levels in healthy adults, with the DAC formulation providing extended action through albumin binding. Clinical evidence for body composition benefits in non-GH-deficient individuals remains limited, and the compound currently falls outside FDA-approved compounding pathways in the US as of 2024. Use in patients with a history of cancer or active malignancy carries meaningful risk due to GH-mediated cell proliferation effects.
  • CJC-1295 is not FDA-approved for any indication, and as of 2023-2024 the FDA placed it outside permissible compounding categories under Sections 503A and 503B.
  • The DAC vs. non-DAC distinction the video describes is pharmacologically real: Jetté et al. (2006) confirmed the DAC form produces GH elevation lasting several days versus minutes for the standard peptide.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • CJC-1295 is not FDA-approved for any indication, and as of 2023-2024 the FDA placed it outside permissible compounding categories under Sections 503A and 503B.
  • The DAC vs. non-DAC distinction the video describes is pharmacologically real: Jetté et al. (2006) confirmed the DAC form produces GH elevation lasting several days versus minutes for the standard peptide.
  • Evidence for fat loss in healthy, non-GH-deficient adults is weak. Most body composition research on GH secretagogues involves patients with diagnosed GH deficiency, not general wellness use.
  • Flushing is a genuinely common side effect and a real reason patients discontinue use, but the video omits potential insulin resistance effects and the uncertain long-term consequences of chronically elevated IGF-1.
  • Elevated IGF-1 from any source carries epidemiological cancer risk associations per Renehan et al. (2004, Lancet), making the cancer caution in this video accurate and worth taking seriously.
  • Posting specific dosing schedules to nearly 100,000 viewers without individual patient screening is a regulatory and safety concern regardless of the end-of-video disclaimer.
  • If you are considering peptide therapy, the starting point is a physician who can order baseline bloodwork and evaluate your personal history, not a dosing protocol from social media.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @ahmadyasinmd actually say?

The video opens with a bold promise: "This peptide can give you lean muscle mass and make you lose fat quickly." Dr. Yasin goes on to describe CJC-1295 as a growth hormone-releasing hormone analog that "amplifies the release of growth hormone naturally," leading to muscle gain, fat loss, better sleep, improved recovery, and neuroprotection. He also plugs combining it with "epimoralin" (ipamorelin) for a "more profound effect," and names specific dosing schedules for both. The disclaimer at the end, "do not buy or use any peptides without talking to your doctor," comes after all of this, which is doing a lot of heavy lifting.

He correctly identifies two forms of CJC-1295, with and without DAC, and flags cancer history as a contraindication. He lists real side effects: flushing, injection site irritation, joint pain and swelling. That part is reasonably accurate. The rest needs a harder look.

Does the science back this up?

Partially, but the phrase "lose fat quickly" is where the evidence starts to sweat. CJC-1295 does stimulate growth hormone release, and growth hormone does have lipolytic effects. But the clinical picture is more complicated than a TikTok caption suggests.

A 2006 study by Jetté et al. in Growth Hormone and IGF Research demonstrated that CJC-1295 produced sustained increases in GH and IGF-1 levels in healthy adults, with effects lasting several days when the DAC formulation was used. That part checks out. But elevated GH and IGF-1 are not the same thing as measurable body composition changes, especially not rapid fat loss. The studies showing body composition benefits from GH secretagogues tend to involve older adults with diagnosed GH deficiency, not healthy individuals looking to optimize. A 2019 review by Garcia et al. in Endocrine Practice noted that evidence for GH secretagogues in healthy adults remains limited and largely anecdotal. The muscle and fat claims in this video overshoot the available data by a meaningful distance.

What did they get wrong (or right)?

Let's give credit where it's due. The DAC versus no-DAC distinction is real and clinically relevant. With DAC, CJC-1295 binds albumin and extends its half-life from minutes to days, producing a more sustained GH elevation. Without DAC, you get a pulse pattern closer to natural GH secretion. That distinction matters for protocol design and the video explains it accurately.

The cancer caution is also correct. Growth hormone signaling can promote cell proliferation, and using any GH secretagogue in someone with active or recent cancer history is genuinely risky. The warning was appropriate.

What he got wrong: calling fat loss "quick" without any evidentiary basis, listing neuroprotection as a benefit with no supporting context, and providing specific dosing numbers on a public platform. Dosing from a TikTok video is not a substitute for clinical evaluation. The ipamorelin combination is used in practice, but presenting a 90-day dosing protocol to 96,000 viewers without individual screening is irresponsible regardless of the disclaimer tacked on at the end.

What should you actually know?

CJC-1295 is not FDA-approved for any indication. It exists in a regulatory gray zone in the United States, where it has been used in compounded form under physician supervision. The FDA placed many peptides including CJC-1295 on its list of drugs that cannot be compounded under Section 503A and 503B in 2023 and 2024, citing insufficient evidence of safety and effectiveness. That context is entirely absent from this video.

The side effect of flushing is real and common enough that the creator notes people stop the medication because of it. Joint pain and swelling are also consistent with GH excess effects. What's missing from the side effect list: potential impact on insulin sensitivity, risk of edema, and the unknown long-term consequences of chronically elevated IGF-1, which has been associated with increased cancer risk in epidemiological data (Renehan et al., 2004, Lancet).

If you are interested in peptide therapy, the conversation belongs in a clinical setting with someone who can review your bloodwork, history, and goals. A 96,000-view TikTok with a dosing schedule is not that setting.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Ahmad Yasin MD · TikTok creator

96.6K views on this video

CJC-1295 Explained: Boost Muscle, Burn Fat, Sleep Better — All with One Peptide 💉 Ever wondered how some peptides help your body naturally boost growth hormone without synthetic injections? Meet CJC-

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about cjc-1295?

CJC-1295 is not FDA-approved for any indication, and as of 2023-2024 the FDA placed it outside permissible compounding categories under Sections 503A and 503B.

What does the video say about the dac vs. non-dac distinction the video describes?

The DAC vs. non-DAC distinction the video describes is pharmacologically real: Jetté et al. (2006) confirmed the DAC form produces GH elevation lasting several days versus minutes for the standard peptide.

What does the video say about evidence for fat loss in healthy, non-gh-deficient adults?

Evidence for fat loss in healthy, non-GH-deficient adults is weak. Most body composition research on GH secretagogues involves patients with diagnosed GH deficiency, not general wellness use.

What does the video say about flushing?

Flushing is a genuinely common side effect and a real reason patients discontinue use, but the video omits potential insulin resistance effects and the uncertain long-term consequences of chronically elevated IGF-1.

What does the video say about elevated igf-1 from any source carries epidemiological cancer risk associations?

Elevated IGF-1 from any source carries epidemiological cancer risk associations per Renehan et al. (2004, Lancet), making the cancer caution in this video accurate and worth taking seriously.

What does the video say about posting specific dosing schedules to nearly 100,000 viewers without individual?

Posting specific dosing schedules to nearly 100,000 viewers without individual patient screening is a regulatory and safety concern regardless of the end-of-video disclaimer.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Ahmad Yasin MD, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.